When was Qualigen Therapeutics, Inc. stock made available for the first time to the public?

The IPO Date for Qualigen Therapeutics, Inc. is 2015-06-23. On this 2015-06-23, Qualigen Therapeutics, Inc. stock was made publicly available.

Where is the headquarters of Qualigen Therapeutics, Inc. stock?

Headquarters of Qualigen Therapeutics, Inc. is in US at 2042 Corte Del Nogal, Carlsbad, CA 92011.

What industry does Qualigen Therapeutics, Inc. belong to?

The Qualigen Therapeutics, Inc. belongs to Biotechnology.

Qualigen Therapeutics, Inc.

QLGN•NASDAQ

Healthcare

Biotechnology

$3.41

$-0.00(-0.09%)

Qualigen Therapeutics, Inc. (QLGN) Company Profile & Overview

Explore Qualigen Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Qualigen Therapeutics, Inc. (QLGN) Company Profile & Overview

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

SectorHealthcare

IndustryBiotechnology

CEOKevin A. Richardson II

Contact Information

https://qlgntx.com

760 918 9165

2042 Corte Del Nogal, Carlsbad, CA, 92011

Company Facts

4 Employees

IPO DateJun 23, 2015

CountryUS

Actively Trading

Frequently Asked Questions

;